Open original FDA record ↗Recall record
- FDA identifier
- Z-0274-2018
- Company in FDA record
- Qiagen, GmbH
- FDA record creation date
- Dec 21, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Certain lots of the QIAamp DSP Virus Kit, REF 60704, used in analytic workflows could result in decreased performance.
Source facts
- Action
- Qiagen sent ffected customers and commercial partners "Urgent Notice of Product Field Action", dated June 22, 2017 via an e-mail containing a letter as pdf. In the letter, customers were informed of the reason for recall, with an overview of affected products, detailed description of issue, consequences of the issue, actions to be taken by the customer/user, completion of the acknowledgement of receipt form, contact information and the commercial partners are instructed to forward , actions that have been initiated by AIAGEN, the letter to their customers.
- Initiated
- 2017-07-22
- Root cause
- Nonconforming Material/Component
- Terminated
- 2018-07-26
- Distribution
- AR; AT; BE; CH; CN; CZ; DE; ES; FR; GB; GR; HK; IN; IR, IT; KR; MX; NL; NP, PH; PK; PL; TR, TW; US; UY, VN
- Recall number
- Z-0274-2018
- Recall status
- Terminated
- CDRH record ID
- 160061
- FDA record created
- 2017-12-21
- Recall event number
- 78646